Skip to main content
SpringerLink
Log in

Characterization of Dopamine D-1 and D-2 Receptors

  • Chapter
Book cover Neurobiology of Central D1-Dopamine Receptors

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 204))

Abstract

DA receptors can be classified into two types, D-1 and D-2 (Kebabian and Calne, 1979). The D-1 receptors are coupled to a DA-dependent adenylate cyclase (AC) in a stimulatory manner, whereas D-2 receptors are independent of AC or coupled in an inhibitory manner (Stoof and Kebabian, 1982).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersen, P.H. and Grønvald, F.C. 1985, A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum, Acta Neurol. Scand., 72:225.

    Google Scholar 

  • Andersen, P.H., Grønvald, F.C. and Aas Jansen, J., 1985, A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum, Life Sci., 37:1971.

    Article  PubMed  CAS  Google Scholar 

  • Andersen, P.H. and Grønvald, F.C, 1986, Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo, Life Sci., in press.

    Google Scholar 

  • Amt, J., Christensen, A.V. and Hyttel, J., 1981, Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential, Neuropharmacology, 20:1331.

    Google Scholar 

  • Arnt, J. and Hyttel, J., 1985, Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology, 85:346.

    Article  PubMed  CAS  Google Scholar 

  • Arnt, J., 1985 a, Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions, Life Sci., 37:717.

    Google Scholar 

  • Arnt, J., 1985 b, Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats, Eur. J. Pharmacol., 113:79.

    Article  PubMed  CAS  Google Scholar 

  • Billard, W., Ruperto, V., Crosby, G., Iorio, L.C. and Barnett, A., 1984, Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum, Life Sci., 35:1885.

    Article  PubMed  CAS  Google Scholar 

  • Burt, D.R., Creese, I. and S.H. Snyder, 1977, Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain, Science, 196:326.

    Article  PubMed  CAS  Google Scholar 

  • Christensen, A.V., Arnt, J. and Svendsen, O., 1985, Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration, in: Dyskinesia — Research & Treatment, Casey, D., Chase, T.N., Christensen, A.V. and Gerlach, J., eds., Springer Verlag, Heidelberg.

    Google Scholar 

  • Christensen, A.V., Arnt, J., Hyttel, J., Larsen, J.-J. and Svendsen, O., 1984, Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics, Life Sci., 34:1529.

    Article  PubMed  CAS  Google Scholar 

  • Christensen, A.V., Arnt, J. and Scheel-Krüger, J., 1979, Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist and an anticholinergic compound. Life Sci., 24: 1395.

    Article  PubMed  CAS  Google Scholar 

  • Christensen, A.V., Arnt, J. and Scheel-Krüger, J., 1980, GABA-dopamine/neu-roleptic interaction after systemic administration, Brain Res. Bull., 5, suppl.2:885.

    Article  CAS  Google Scholar 

  • Christensen, A.V. and Hyttel, J., 1981, Prolonged treatment with the GABA agonist THIP increases dopamine receptor binding more than it changes dopaminergic behaviour in mice, Drug Develop. Res., 1:255.

    Article  CAS  Google Scholar 

  • Christensen, A.V. and Hyttel, J., 1982, Neuroleptics and the clinical implications of adaptation of dopamine neurons, Pharmacy International, 3:329.

    CAS  Google Scholar 

  • Clement-Cormier, Y.C., Kebabian, J.W., Petzold, G.L. and Greengard, P., 1974, Dopamine-sensitive adenylate cyclase in mammalian brain: A possible site of action of antipsychotic drugs, Proc. Nat. Acad. Sci. U.S.A., 71:1113.

    Article  CAS  Google Scholar 

  • Costall, B., Kelly, M.E. and Naylor, R.J., 1983, Does contralateral circling involve action of drugs on hyposensive striatal dopamine receptors in the hemisphere contralateral to denervation?, Neuropharmacology, 22:295.

    Article  PubMed  CAS  Google Scholar 

  • Creese, I., Burt, D.R. and Snyder, S.H., 1976, Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science, 192:481.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J., Crow, T.J. and Owen, F., 1981, 3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in D 2 receptors, Psychopharmacology, 74:122.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J., Marshal, R.D., Johnson, J.A. and Owen, F., 1983, Preferential inhibition of ligand binding to calf striatal dopamine D-1 receptors by SCH 23390, Neuropharmacology, 22:1327.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J. and Owen, F., 1980, Characteristics of 3H-cis-flupenthixol binding to calf brain membranes, Eur. J. Pharmacol., 65:341.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J. and Rossor, M., 1983, Dopamine D-1 and D-2 receptors in Huntington’s disease, Eur. J. Pharmacol., 88:223.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J. and Waddington, J.L., 1981, Kainic acid lesions dissociate (3H)spiperone and (3H)cis-flupenthixol binding sites in rat striatum, Eur. J. Pharmacol., 71:327.

    Article  PubMed  CAS  Google Scholar 

  • Crow, T.J., Cross, A.J., Johnstone, E.C., Owen, F., Owens, D.G.C. and Waddington, J.L., 1981, Tardive dyskinesia — Disease process or drug effect? in: Biological Psychiatry, C. Perris, G. Stuwe and B. Jansson, eds., Elsevier/North-Holland Biomedical Press.

    Google Scholar 

  • Crow, T.J., Cross, A.J., Johnstone, E.C., Owen, F., Owens, D.G.C. and Waddington, J.L., 1982, Abnormal involuntary movements in schizophrenia: Are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? J. Clin. Psychopharmacol., 2:336.

    Article  PubMed  CAS  Google Scholar 

  • Davies, S.W., Templeton, W.W. and Woodruff, G.N., 1982, Reduction of specific (3H)cis-flupenthixol binding sites in rat striatum following decortication, Br. J. Pharmacol., 77:358P.

    Google Scholar 

  • Fleminger, S., Hall, M.D., Jenner, P., Kilpatrick, G., Mann, S., Marsdem, C.D. and Rupniak, N.M.J., 1984, Differential effects of administration of haloperidol, sulpiride or clozapine for 12 months on rat striatal function, Br. J. Pharmacol., 82:288P.

    Google Scholar 

  • Fleminger, S., Jenner, P., Marsden, C.D. and Rupniak, N.M.J., 1982, Dopamine receptor supersensitivity produced by repeated neuroleptic administration correlates with increased D-2 receptors, Br. J. Pharmacol., 77:456P.

    Google Scholar 

  • Fleminger, S., Rupniak, N.M.J., Hall, M.D., Jenner, P. and Marsden, C.D., 1983, Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors, Biochem. Pharmacol., 19:2921.

    Article  Google Scholar 

  • Gredal, O., Nielsen, M. and Hyttel, J., 1986, Target size of dopamine D-1 receptors in rat corpus striatum estimated by 3H-SCH 23390 binding. Eur. J. Pharmacol., submitted.

    Google Scholar 

  • Herrera-Marschitz, M., and Ungerstedt, U., 1985, Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats, Eur. J. Pharmacol., 109:349.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1978 a, Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)- flupenthixol binding and on adenylate cyclase activity in vitro, Life Sci., 23:551.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1978 b, A comparison of the effect of neuroleptic drugs on the binding of 3H-haloperidol and 3H-cis(Z)-flupenthixol and on adenylate cyclase activity in rat striatal tissue in vitro, Prog. Neuro-Psychopharmacol., 2:329.

    Article  CAS  Google Scholar 

  • Hyttel, J., 1980, Further evidence that 3H-cis(Z)-flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum, Psychopharmacology, 67:107.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1981, Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro, Life Sci., 28:563.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1982, Preferential labelling of adenylate cyclase coupled dopamine receptors with thioxanthene neuroleptics, in: Advances in dopamine research, M. Kohsaka, T. Shomori, Y. Tsukada and G.N. Woodruff, eds., Advances in the biosciences, 37:147. Pergamon Press, Oxford.

    Google Scholar 

  • Hyttel, J., 1983, SCH 23390 — The first selective dopamine D-1 antagonist, Eur. J. Pharmacol., 91:153.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1984, Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390, Neuropharmacology, 23:1395.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel, J., 1985, Dopamine D-1 and D-2 receptors. Characterization and differential effects of neuroleptics, Proceedings of the VIIIth International Symposium on Medicinal Chemistry, Dahlbom, R. and Nilsson, J.L.G., eds., Acta Pharmaceutica Suecica, suppl. 1:426.

    Google Scholar 

  • Hyttel, J., 1986, Effect of prolonged treatment with neuroleptics on dopamine D-1 and D-2 receptor number in corpus striatum of rat and mouse, J. Neural. Transmission, in press.

    Google Scholar 

  • Hyttel, J. and Arnt, J., 1986, Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions, J. Neural. Transmission, in press.

    Google Scholar 

  • Hyttel, J. and Christensen, A.V., 1983, Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors, J.Neu-ral.Transmiss., supp. 18:157.

    CAS  Google Scholar 

  • Hyttel, J. and Christensen, A.V., 1984, Do dopamine D-1 receptors contribute to the antipsychotic effects and side effects of neuroleptic drugs ?. Clin. Neuro-pharmacol. 7, suppl. 1:546.

    Google Scholar 

  • Hyttel, J., Christensen, A.V. and Arnt, J., 1983, Neuroleptic classification: Implications for tardive dyskinesia, Mod.Probl. Pharmacopsychiat., 21:49.

    CAS  Google Scholar 

  • Iorio, L.C., Barnett, A., Leitz, F.H., Houser, V.P. and Korduba, C.A., 1983, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J.Pharmacol. exp. Ther., 226:462.

    PubMed  CAS  Google Scholar 

  • Jenner, P., Elliott, P.N.C, Clow, A., Reavill, C and Marsden, C.D., 1978, A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs, J. Pharm. Pharmacol., 30:46.

    Article  PubMed  CAS  Google Scholar 

  • Jenner, P., Kilpatrick, G.J. and Marsden, C.D., 1984, CHAPS solubilises D2 but not D1-binding sites from rat striatal preparations, Br. J. Pharmacol., 81:52P.

    Google Scholar 

  • Kebabian, J.W. and Calne, D.B., 1979, Multiple receptors for dopamine, Nature, 277:93.

    Article  PubMed  CAS  Google Scholar 

  • Laduron, P., 1976, Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase, J.Pharm. Pharmacol., 28:250.

    Article  PubMed  CAS  Google Scholar 

  • Laduron, P.M. and Leysen, J.E., 1979, Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity, Biochem. Pharmacol., 28:2161.

    Article  PubMed  CAS  Google Scholar 

  • Leff, S., Lynne, A., Hyttel, J. and Creese, I., 1981, Kainate lesion dissociates striatal dopamine receptor radioligand binding sites, Eur. J. Pharmacol., 70:71.

    Article  PubMed  CAS  Google Scholar 

  • Lerner, M.H., Rosengarten, H. and Friedhoff, A.J., 1981, Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate, Life Sci., 29:2367.

    Article  PubMed  CAS  Google Scholar 

  • Leysen, J.E., 1984, Receptors for neuroleptic drugs, Advances in Human Psychopharmacology, 3:315.

    CAS  Google Scholar 

  • Leysen, J.E., Gommeren, W. and Laduron, P.M., 1978, Spiperone: A ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding, Biochem.Pharmacol., 27:307.

    Article  PubMed  CAS  Google Scholar 

  • Lilly, L., Frazer, C.M., Jung, C.Y., Seeman, P. and Venter, J.C., 1983, Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation, Mol. Pharmacol., 24:10.

    PubMed  CAS  Google Scholar 

  • Miller, R.J., Horn, A.S. and Iversen, L.L., 1974, The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3’,5’-monophosphate production in rat neostriatum and limbic forebrain, Mol.Pharmacol., 10:759.

    CAS  Google Scholar 

  • Murrin, L.C, 1983, Characteristics of 3H-cis-flupenthixol binding in rat striatum, Life Sci., 33:2179.

    Article  PubMed  CAS  Google Scholar 

  • Murugaiah, K., Fleminger, J., Theodorou, A., Jenner, P., Marsden, C.D., 1983, Persistant increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake, Biochem. Pharmacol., 32:2495.

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M., Klimek, V. and Hyttel, J., 1984, Distinct target size of dopamine D-1 and D-2 receptors in rat striatum, Life Sci., 35:325.

    Article  PubMed  CAS  Google Scholar 

  • O’Boyle, K.M. and Waddington, J.L., 1984, Selective and stereospecific interactions of R-SK & F 38393 with (3H)piflutixol but not (3H)spiperone binding to striatal D1 and D2 dopamine receptors: Comparison with SCH 23390, Eur.J.Pharmacol., 98:433.

    Article  PubMed  Google Scholar 

  • O’Boyle, K.M. and Waddington, J.L., 1984, Loss of rat striatal dopamine receptors with agening is selective for D-2 but not D-1 sites: Association with increased non-specific binding of the D-1 ligand (3H) piflutixol. Eur. J. Pharmacol., 105:171.

    Article  PubMed  Google Scholar 

  • Owen, F., Cross, A.J., Crow, T.J., Poulter, M. & Waddington, J.L., 1981, Increased dopamine receptors in schizophrenia: Specificity and relationship to drugs and symptomtology, in: Biological psychiatry. C. Perris, G. Stuwe and B. Jansson, eds., Elsevier/North-Holland Biomedical Press.

    Google Scholar 

  • Owen, F., Cross, A.J., Waddington, J.L., Poulter, M., Gamble, S.J. and Crow T.J., 1980, Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration, Life Sci., 26:55.

    Article  PubMed  CAS  Google Scholar 

  • Pimoule, C., Schoemaker, H., Reynolds, G.P. and Langer, S.Z., 1985, (3H) SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and parkinson’s disease, Eur. J. Pharmacol., 114:235.

    Article  PubMed  CAS  Google Scholar 

  • Porceddu, M.L., Ongini, E. and Biggio, G., 1985, (3H) SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors. Eur. J. Pharmacol., 118:367.

    Article  PubMed  CAS  Google Scholar 

  • Portaleone, P., Crispino, A. and DiCarlo, R., 1978, Effect of substituted benzamides on the cAMP system in the hypothalamus and striatum of the rat, Neurosci. lett., 9:233.

    Article  PubMed  CAS  Google Scholar 

  • Raisman, R., Cash, R., Ruberg, M. Javoy-Agid, F. and Agid, Y., 1985, Binding of (3H) SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects, Eur. J. Pharmacol., 113:467.

    Article  PubMed  CAS  Google Scholar 

  • Schultz, D.W., Stanford, E.J., Wyrick, S.W. and Mailman, R.B., 1985, Binding of (3H) SCH 23390 in rat brain: Regional distribution and effects of assay conditions and GTP suggest interaction of a D1-like dopamine receptor. J. Neurochem., 45:1601.

    Article  Google Scholar 

  • Schwarcz, R., Creese, I., Coyie, J.T. and Snyder, S.H., 1978, Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum, Nature, 271:766.

    Article  PubMed  CAS  Google Scholar 

  • Seeman, P., 1980, Brain dopamine receptors, Pharmacol.Rev., 32:229.

    PubMed  CAS  Google Scholar 

  • Snyder, S.H., Creese, I. and Burt, D.R., 1975, The brain’s dopamine receptor: Labelling with (3H) dopamine and (3H) haloperidol, Psychopharmacol. Commun., 1: 663.

    PubMed  CAS  Google Scholar 

  • Stoof, J.C. and Kebabian, J.W., 1982, Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+- stimulated release of acetylcholine from rat neostriatum, Brain Res., 250:263.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, H. Lundbeck A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark

    John Hyttel & Jørn Arnt

Authors
  1. John Hyttel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jørn Arnt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of North Carolina at Chapel Hill, Chapel Hill, North Caronila, USA

    George R. Breese

  2. University of California, San Diego, La Jolla, Carlifornia, USA

    Ian Creese

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Hyttel, J., Arnt, J. (1986). Characterization of Dopamine D-1 and D-2 Receptors. In: Breese, G.R., Creese, I. (eds) Neurobiology of Central D1-Dopamine Receptors. Advances in Experimental Medicine and Biology, vol 204. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5191-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5191-7_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5193-1

  • Online ISBN: 978-1-4684-5191-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation